Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Centre, International, Randomised, Vehicle Controlled, Parallel-Group, Double-Blinded Phase 2 Trial of BB2603 Topical Treatment in Subjects With Distal Subungual Onychomycosis (DSO) of the Toenail

NCT04188574 is registered in ClinicalTrials.gov with Blueberry Therapeutics as lead sponsor.

NCT NCT04188574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04188574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Centre, International, Randomised, Vehicle Controlled, Parallel-Group, Double-Blinded Phase 2 Trial of BB2603 Topical Treatment in Subjects With Distal Subungual Onychomycosis (DSO) of the Toenail
Lead sponsor
Blueberry Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
March 22, 2021
Completion date
June 28, 2023
Enrollment
111 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

distal subungual onychomycosis, fungal infection, fungus, nail